Soligenix Share Price

Soligenix Share Price

NASDAQ: SNGX | Micro Cap | Healthcare
$0.25
+$0.25 (--%) Last updated on 18 Nov, 2026 | 21:11 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Soligenix Stock Performance

Open
$0.25
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.25 - $0.25
Year Range
$0.25 - $1.69
Volume
100
Average Traded
$0.25

Soligenix Share Price Chart

Line chart of the Soligenix price trend over the selected period. The price rose overall, ranging from 0.25 to 0.25, ending at 0.25.
$0.25$0.25
L
Show Current Price
H

Soligenix Stock Fundamentals & Key Indicators

Market Cap
$1.30M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.38
Revenue (TTM)
$0.00
Return On Equity (TTM)
-141.10%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
61.38%

Soligenix Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.90-$2.82-$1.99-$1.12
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A2.76%29.43%43.72%

Soligenix Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.95$0.84$0.12$0.00
Net Profit-$13.80-$6.14-$8.27-$11.08
Net Profit Margin-1452.63%-730.95%-6891.67%N/A
Income ChangeN/A55.51%-34.69%-33.98%

Soligenix Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.390.140.290.43
Current Assets8.858.839.5113.85
Total Assets9.248.979.814.28
Non Current Liabilities0.240.01.120.23
Current Liabilities3.74.856.1516.52
Total Liabilities3.944.857.2716.75
Shareholders' Equity5.294.122.52-2.47

Soligenix Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-10.27-8.4-8.6-12.65
Investing-0.010.00.0-0.01
Financing10.397.763.660.08

Corporate Actions

Split
Ex-date: 06 Jun 2024

Split
Ex-date: 10 Feb 2023

Split
Ex-date: 30 Dec 2022

About Soligenix

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Soligenix Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.36
$0.25
-29.78%
Oct 2026
$0.36
$0.36
-1.66%
Sep 2026
$0.38
$0.36
-10.84%
Aug 2026
$0.37
$0.41
+9.14%
Jul 2026
$0.41
$0.37
-7.69%
Jun 2026
$0.84
$0.40
-56.29%
May 2026
$0.35
$0.92
+163.43%
Apr 2026
$1.21
$0.35
-70.34%
Mar 2026
$1.15
$1.18
+0.00%
Feb 2026
$1.25
$1.18
-5.60%
Jan 2026
$1.36
$1.25
-6.72%
Dec 2025
$1.57
$1.34
-15.99%

Soligenix Share Price FAQs